REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medy-Tox Inc. (South Korea)

Main Activities: Chemical Manufacturing | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Medy-Tox Inc. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

medytox inc is a company in the botulinum toxin industry. The company focuses on developing bio-medicines and medical aesthetics products. medytox inc invests over 15% of its total sales in research and development. The company offers products such as Neuramis, a hyaluronic acid filler, and Inotox, a botulinum toxin preparation. medytox inc exports its products to more than 60 countries worldwide.

Headquarters
641-4 Gak-Ri, Ochang-Myeon, Cheongwon-Gun
Chungcheonbuk-Do; Postal Code: 363-883

Contact Details: Purchase the Medy-Tox Inc. report to view the information.

Website: http://www.medytox.com

Basic Information
Total Employees:
Purchase the Medy-Tox Inc. report to view the information.
Outstanding Shares:
Purchase the Medy-Tox Inc. report to view the information.
Registered Capital:
Purchase the Medy-Tox Inc. report to view the information.
Financial Auditors:
Purchase the Medy-Tox Inc. report to view the information.
Incorporation Date:
May 02, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
18.34%
Purchase this report to view the information.
3.03%
Purchase this report to view the information.
0.2%
Purchase this report to view the information.
0.14%
Purchase this report to view the information.
0.01%
Subsidiaries
(주)메디톡스코리아
100%
(주)메디톡스벤처투자
(주)벙커엠
Company Performance
Financial values in the chart are available after Medy-Tox Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
26.6%▲
Total operating revenue
27.18%▲
Operating profit (EBIT)
27.81%▲
EBITDA
123.03%▲
Net Profit (Loss) for the Period
-29.86%▼
Total assets
0.97%▲
Total equity
-2.26%▼
Operating Profit Margin (ROS)
0.09%▲
Net Profit Margin
-6.64%▼
Return on Equity (ROE)
-0.81%▼
Quick Ratio
-0.19%▼
Cash Ratio
-0.26%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo